Literature DB >> 10541828

Effects of low-dose dobutamine on left ventricular function in normal subjects as assessed by gated single-photon emission tomography myocardial perfusion studies.

H Everaert1, C Vanhove, P R Franken.   

Abstract

Electrocardiography gated single-photon emission tomography (gated SPET) allows the assessment of regional perfusion and function simultaneously and in full spatial congruency. In this study changes in global and regional left ventricular function in response to dobutamine infusion were assessed in ten healthy volunteers using sequential gated SPET myocardial perfusion acquisitions. Four consecutive gated SPET images were recorded 60 min after injection of 925 MBq technetium-99m tetrofosmin on a three-head camera equipped with focussing collimators. Two acquisitions were made at rest (baseline 1 and 2), and the third and fourth acquisitions were started 5 min after the beginning of the infusion of 5 and 10 microg kg(-1) min(-1) dobutamine, respectively. Systolic wall thickening (WT) was quantified using a method based on circumferential profile analysis. Left ventricular ejection fraction (LVEF) and volumes were calculated automatically using the Cedars-Sinai program. Nine of the ten subjects presented a definite increase in WT during dobutamine infusion. WT increased on average from 46%+/-14% at baseline to 71%+/-23% (range: 37%-106%; P<0.05) during 5 microg kg(-1) min(-1) dobutamine infusion and to 85%+/-25% (range: 62%-123%; P<0.05 with respect to WT at 5 microg kg(-1) min(-1)) during 10 microg kg(-1) min(-1) dobutamine infusion. Apical segments showed the largest WT at baseline. The average WT response to dobutamine was similar for all parts of the myocardium. It is concluded that changes in WT induced by infusion of low-dose dobutamine can be assessed by sequential gated SPET myocardial perfusion studies. The "stress gated SPET" protocol proposed in this study might be helpful to distinguish viable from scar tissue in patients with coronary artery disease, by demonstrating a preserved inotropic response in hypoperfused myocardium.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10541828     DOI: 10.1007/s002590050586

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  6 in total

1.  Abnormal response to inotropic stimulation in young asymptomatic type I diabetic patients demonstrated by serial gated myocardial perfusion SPECT imaging.

Authors:  C Weytjens; B Cosyns; G Van Camp; C Daniels; K Spincemaille; A Dupont; P R Franken
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-08-17       Impact factor: 9.236

2.  Single injection, double acquisition: a double-edged sword?

Authors:  Ernst E van der Wall; Yves G America; Arthur J Scholte; Jeroen J Bax
Journal:  Int J Cardiovasc Imaging       Date:  2008-07-24       Impact factor: 2.357

3.  Assessment of perfusion, function, and myocardial metabolism after infarction with a combination of low-dose dobutamine tetrofosmin gated SPECT perfusion scintigraphy and BMIPP SPECT imaging.

Authors:  H Everaert; C Vanhove; P R Franken
Journal:  J Nucl Cardiol       Date:  2000 Jan-Feb       Impact factor: 5.952

4.  Low-dose dobutamine nitrate-enhanced technetium 99m sestamibi gated SPECT versus low-dose dobutamine echocardiography for detecting reversible dysfunction in ischemic cardiomyopathy.

Authors:  Mario Leoncini; Roberto Sciagrà; Francesco Bellandi; Mauro Maioli; Stelvio Sestini; Gabriella Marcucci; Angela Coppola; Fabio Frascarelli; Alberto Mennuti; Roberto P Dabizzi
Journal:  J Nucl Cardiol       Date:  2002 Jul-Aug       Impact factor: 5.952

5.  Stress-related variations in left ventricular function as assessed with gated myocardial perfusion SPECT.

Authors:  Hein J Verberne; Marcel G W Dijkgraaf; G Aernout Somsen; Berthe L F van Eck-Smit
Journal:  J Nucl Cardiol       Date:  2003 Sep-Oct       Impact factor: 5.952

Review 6.  The expanding role of left ventricular functional assessment using gated myocardial perfusion SPECT: the supporting actor is stealing the scene.

Authors:  Roberto Sciagrà
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-07       Impact factor: 10.057

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.